ESPR 8-K 2026-07-13

Esperion Therapeutics, Inc. (ESPR) 8-K dated 2026-07-13 — accession 0001104659-26-082926. This URL is the filing, not the ESPR hub.

Esperion Therapeutics, Inc. (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Esperion Therapeutics, Inc. filed a 8-K on 2026-07-13. Accession 0001104659-26-082926.

Cached items: 1.01, 1.02, 2.01, 2.03, 3.01, 3.03. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ESPR revenue for 2025-12-31 was $403.1M. Net income was -$22.7M. Revenue was up 21.3% from 2024-12-31 to 2025-12-31. ESPR currently screens at market cap $816.9M.

Not investment advice. The ESPR SEC hub lists recent forms. The stock page is the research view.